Grunenthal names new chief commercial officer
23 November 2022 -

Grunenthal, a German, science-based, fully integrated pharmaceutical company, announced on Tuesday that it has named Janneke van der Kamp as its new chief commercial officer effective 1 March 2023.

van der Kamp has served as head of Pharma Region Europe at Novartis. She has served in various roles including general manager, global neurosciences franchise head and global head of Product and Portfolio Strategy for the entire Novartis Pharma range.

In the new role, van der Kamp will be responsible for the entire Global Commercial Organisation and serve as a member of the Corporate Executive Board. She will continue to grow the firm's key brands, prepare for the introduction of the company's pipeline assets and increase the range of established medicines.